Etoposide Injection, Solution, Concentrate
Product Images NDC 71288-177

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 71288-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 100 mg per 5 mL Carton Label)

Packaging label for Etoposide Injection, USP 100 mg per 5 mL (20 mg per mL) concentrate for intravenous infusion. The box includes a warning that it is a cytotoxic agent and should be diluted before use. It is a 5 mL multiple-dose vial by Meitheal Pharmaceuticals Inc. Storage instructions and formulation details are also included on the label.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 100 mg per 5 mL Vial Label)

Label for Etoposide Injection, USP concentrate, 100 mg per 5 mL (20 mg/mL) in a 5 mL multiple-dose vial. The label states it must be diluted before intravenous infusion. It includes ingredients, storage instructions, and is labeled by Meitheal Pharmaceuticals Inc., made in China.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 1 gram per 50 mL Carton Label)

Etoposide Injection, USP 1 gram per 50 mL (20 mg/mL) solution concentrate for intravenous infusion by Meitheal Pharmaceuticals Inc. The carton includes warnings about cytotoxicity and instructions to dilute before intravenous use. It is labeled as a sterile, nonpyrogenic, preservative-free multi-dose vial with storage instructions and excipient details.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 1 gram per 50 mL Vial Label)

Label for Etoposide Injection, USP, 20 mg/mL (1 gram per 50 mL) solution concentrate for intravenous use. The multiple-dose vial contains 50 mL and must be diluted before infusion. Manufactured by Meitheal Pharmaceuticals Inc., with dosage and storage details included on the label.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 500 mg per 25 mL Carton Label)

Packaging label for Etoposide Injection, USP concentrate, 20 mg/mL (500 mg per 25 mL) by Meitheal Pharmaceuticals Inc. The label includes a warning that it is a cytotoxic agent requiring dilution before intravenous infusion and indicates a multiple-dose 25 mL vial. Storage instructions, preservative information, and a barcode are also present.*

FDA Label Image

Package Label Principal Display Panel (Etoposide Injection, USP 500 mg per 25 mL Vial Label)

Etoposide Injection, USP 500 mg per 25 mL (20 mg per mL) solution concentrate for intravenous use. The label indicates it is a 25 mL multiple-dose vial, must be diluted before infusion, and lists active and inactive ingredients. The labeler is Meitheal Pharmaceuticals Inc., and the product is Rx only.*

FDA Label Image

Structural Formula (Etoposide Structure)

Chemical structure of Etoposide, depicting its molecular framework including multiple hydroxyl, methoxy, and carbonyl groups, along with the molecular formula C29H32O13 and molecular weight 588.56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.